KO

KOREAN DRUG CO., LTD.

Develops and manufactures prescription (ETC) and over-the-counter (OTC) medicines for public health.

014570 | KO

Overview

Corporate Details

ISIN(s):
KR7014570006
LEI:
Country:
South Korea
Address:
경기도 이천시 신둔면 원적로 69-10, 이천시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Korean Drug Co., Ltd. is an established pharmaceutical company with over 50 years of experience in developing, manufacturing, and marketing therapeutic drugs. The company's portfolio includes both prescription (ETC) medicines for various conditions and over-the-counter (OTC) products, such as its 'Geunalen' brand of painkillers. Leveraging state-of-the-art production facilities and proprietary technology, the company produces a range of finished pharmaceutical products, and its offerings may also extend to health supplements and medical supplies. The company is committed to developing high-quality medicines for public health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.1 MB
2025-08-13 00:00
Transaction in Own Shares
자기주식처분결과보고서
Korean 16.2 KB
2025-08-11 00:00
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
Korean 28.5 KB
2025-07-02 00:00
Transaction in Own Shares
자기주식처분결과보고서
Korean 16.3 KB
2025-06-30 00:00
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
Korean 28.6 KB
2025-06-05 00:00
Transaction in Own Shares
자기주식처분결과보고서
Korean 16.3 KB
2025-06-02 00:00
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
Korean 28.6 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1019.2 KB
2025-03-21 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 23.7 KB
2025-03-21 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 12.6 KB
2025-03-13 00:00
Audit Report / Information
감사보고서제출
Korean 18.4 KB
2025-03-13 00:00
Annual Report
사업보고서 (2024.12)
Korean 444.5 KB
2025-03-06 00:00
Transaction in Own Shares
자기주식처분결과보고서
Korean 16.3 KB
2025-03-04 00:00
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
Korean 28.5 KB
2025-02-26 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 102.6 KB

Automate Your Workflow. Get a real-time feed of all KOREAN DRUG CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KOREAN DRUG CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KOREAN DRUG CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Bulgaria
PHRM
Pharmicell Co.,Ltd. Logo
Biopharma firm in stem cell therapies, biochemicals, cell banking, and stem cell cosmetics.
South Korea
005690
Pharming Group N.V. Logo
Develops & commercializes protein & precision medicines for rare, life-threatening diseases.
Netherlands
PHARM
Pharmocann Global Ltd. Logo
Develops pharma-grade medical cannabis products like oils, ointments, tablets, and cosmetics.
Israel
PMCN-M
Pharvaris N.V. Logo
Developing oral therapies for rare angioedema to treat and prevent attacks.
United States of America
PHVS
Phathom Pharmaceuticals, Inc. Logo
Develops and commercializes treatments for acid-related gastrointestinal diseases.
United States of America
PHAT
Pherecydes Pharma Logo
Develops precision phage therapy to treat resistant bacterial infections.
France
ALPHE
PHIBRO ANIMAL HEALTH CORP Logo
Develops animal health products, vaccines, and nutrition for livestock and companion animals.
United States of America
PAHC
Philogen Logo
Developing targeted biopharmaceuticals for oncology using proprietary ligand-based delivery.
Italy
PHIL
Phio Pharmaceuticals Corp. Logo
Developing RNAi-based immuno-oncology therapeutics for melanoma and other skin cancers.
United States of America
PHIO

Talk to a Data Expert

Have a question? We'll get back to you promptly.